Tiverton Asset Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$135K Hold
8,673
﹤0.01% 607
2019
Q2
$176K Hold
8,673
0.01% 567
2019
Q1
$153K Hold
8,673
0.01% 544
2018
Q4
$111K Buy
+8,673
New +$111K 0.01% 357